ReviewNew microbes and new infections2026
Antifungal activity of propolis against Candida spp.
Review in New microbes and new infections, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fungal infections caused by Candida species remain a major clinical and pharmacological challenge, ranging from superficial mucocutaneous disease to invasive infections associated with considerable morbidity. Vulvovaginal candidiasis is among the most common manifestations and is frequently recurrent. Increasing antifungal resistance has reduced the effectiveness of azoles and other standard therapies, highlighting the need for alternative or complementary treatment strategies. This systematic review aimed to synthesize recent evidence on the antifungal activity of propolis and its mechanisms of action against Candida species. A systematic literature search was conducted in Scopus and ScienceDirect in accordance with PRISMA 2020 guidelines. Original English-language studies published between 2015 and 2025 were included. Evidence from in vitro, in vivo, and clinical studies evaluating antifungal activity, biofilm inhibition, and mechanistic outcomes was synthesized.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.